José Luís Morgado Pascual-rekin lankidetzan egindako argitalpenak (6)

2023

  1. BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease

    Antioxidants, Vol. 12, Núm. 5

  2. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis

    Pharmaceuticals, Vol. 15, Núm. 2

2019

  1. Bromodomain and extraterminal proteins as novel epigenetic targets for renal diseases

    Frontiers in Pharmacology, Vol. 10

2018

  1. Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology

    Mediators of Inflammation, Vol. 2018

2017

  1. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage

    Journal of the American Society of Nephrology, Vol. 28, Núm. 2, pp. 504-519